Deepinder Goyal’s Temple plans pre-orders for limited-edition brain-health wearable
Temple, Deepinder Goyal’s health-wearable venture, is preparing pre-orders for a smaller limited launch edition of its cerebral blood-flow tracking device. The wearable is expected to cost ₹75,000–80,000, with initial shipments targeted before the end of 2026.
What happened
Deepinder Goyal’s health-wearable venture Temple will soon open pre-orders for a smaller limited launch edition, with deliveries targeted by end-2026. The
Key facts
- Temple is less than half the size of its earlier version
- Expected price: ₹75,000–80,000
- Expected next funding valuation: around $500 million
- ESOP buyback valuation: $375 million
- Raised $54 million in February at a $190 million valuation
- More than 80 individual investors
Why this matters
Temple’s move toward commercialization makes it a potential partnership target for premium wellness retailers, diagnostic networks and consumer-health platforms seeking differentiated brain-health offerings.
What to watch
- Preorder pricing, deposit size, refund terms and stated production volume.
- Whether Temple discloses clinical-study results, peer-reviewed evidence or regulatory status.
- Language used in marketing: cerebral blood-flow monitoring, brain-health guidance, performance optimization or disease-related claims.
- Initial shipment timing versus the before-end-2026 target.
- Partnership announcements with hospitals, clinics, insurers, researchers or enterprise wellness buyers.
- Evidence of a recurring subscription or paid analytics layer.
- Customer feedback on comfort, battery life, actionable insight quality and data privacy.
- Open a controlled preorder/waitlist program with refundable deposits, eligibility screening and explicit shipment windows.
- Use limited-edition design, founder access and scarcity messaging to position the product as luxury preventive-health technology rather than a fitness tracker.
- Publish technical validation, accuracy methodology, contraindications and a clear boundary between wellness insights and medical diagnosis.
- Build partnerships with neurologists, longevity clinics, diagnostic centers and corporate executive-health programs.
- Test subscription tiers for interpretation, longitudinal reports, coaching and clinician-reviewed insights.
- Prioritize concierge onboarding and post-purchase support to reduce returns and protect brand trust at the premium price point.